The U.S. Can’t Afford Not to Have a Cure for Diabetes

Spending on diabetes care takes up a significant slice of the GDP, and that slice will only get bigger.

insulin_nation_us_cant_afford_no_diabetes_cure_945px



A person with diabetes knows that managing this chronic condition can take up a large chunk of one’s personal budget. It’s a bit harder to picture how much diabetes costs the entire U.S. economy, but the thought exercise is eye-opening.

Here are some statistics to put the enormity of managing diabetes into perspective.

According to the Centers for Medicaid and Medicare Services, the national health care expenditure, in total, for 2014 was $3 trillion, growing 5.3 percent for the year, and making up 17.5 percent of the 2014 gross domestic product (“GDP”). Prescription drug spending grew 12.2 percent, while hospital spending grew 4.1 percent. A July 2016 Associated Press story projected the 2016 spending at $3.35 trillion, slightly below the number projected by CMS.

insulin_nation_diabetes_price_usa-01

According to the American Diabetes Association (ADA), people with diabetes account for one-fifth of the annual U.S. health care expenditure and one-third of Medicare expenditures, or $600 billion a year. The biggest expense, by far, was hospital inpatient care and residential extended care services, which makes up 51 percent of that expense. Medicines to treat complications of diabetes in addition to glucose control medications and testing supplies make up 30 percent of that expense and visits with physicians make up 9 percent.

insulin_nation_diabetes_price_usa-02

The ADA finds that people who manage their diabetes spend 3.9 times more for health care than people who don’t have diabetes. In July, the PBS NewsHour aired a story projecting annual per capita expense for all Americans at $10,345. The per capita annual expense for diabetes care, based on 2014 CDC projections, will come in much higher — at $16,021.

insulin_nation_diabetes_price_usa-03

Through 2025, health care spending, per capita, is projected to grow by 4.8% a year, 1.3% faster than GDP. (Source: CMS). If this curve holds true, 20.1% of GDP in 2025 will be attributable to health care services and prescription medications.


Such data seems to suggest that if the government wants to curb healthcare costs, it should put at least some focus on cure research. Managing a chronic condition is expensive for everyone. Stopping the condition from being chronic, even if it costs billions of dollars to do, might be cheaper in the long run.

Craig Idlebrook contributed to this report.

Thanks for reading this Insulin Nation article. Want more Type 1 news? Subscribe here.

Have Type 2 diabetes or know someone who does? Try Type 2 Nation, our sister publication.

Sponsor

Sponsor

Share this Article:

Jim Cahill is a senior writer for Insulin Nation and Type 2 Nation. Before turning to writing, he was a lawyer in government and private practice who focused on consumer protection and regulatory law. He can be contacted at jcahill@epscomm.com.